Cornerstone Pharmaceuticals Email Format

Pharmaceutical ManufacturingNew Jersey, United States11-50 Employees

Cornerstone Pharmaceuticals is a clinical-stage pharmaceutical manufacturer focused on exploiting altered energy metabolism in cancer. Its work centers on developing and advancing anti-cancer agents that target mitochondrial energy pathways in cancer cells, with CPI-613 highlighted as the lead compound under evaluation in multiple early-stage trials. The company aims to improve cancer treatment safety and efficacy by focusing on regulatory processes unique to cancer cells and minimizing effects on normal tissues. Based in Newark, New Jersey, Cornerstone operates in the pharmaceutical manufacturing sector and targets oncology patients with hard-to-treat cancers through its research and development programs. The organization positions itself as a developer of novel, first-in-class therapies and delivery approaches derived from an understanding of cancer-specific bio-energetic processes, pursuing clinical progress across various trial phases and combinations with standard therapies.

Get verified Cornerstone Pharmaceuticals emails free

Company overview Employee directory